Portal de Periódicos da CAPES

Synthesis, bioassay, crystal structure and ab initio studies of Erlenmeyer azlactones

2012; Elsevier BV; Volume: 104; Linguagem: Inglês

10.1016/j.saa.2012.11.054

1873-3557

Mehtab Parveen, Akhtar Ali, Sarfaraz Ahmed, Ali Mohammed Malla, Mahboob Alam, Pedro Silva, Manuela Ramos Silva, Dong‐Ung Lee,

Bioactive Compounds and Antitumor Agents

Several 4-arylidene-2-phenyl-5(4H)-azlactones have been synthesized via Erlenmeyer method. The synthesized compounds have been characterized on the basis of systematic spectral studies (IR, 1H NMR, 13C NMR, and MS). The compound (4Z)-4-(3,5-dimethoxybenzylidene)-2-phenyl-1,3-oxazol-5(4H)-one, C18H15NO4, (5), crystallizes in the orthorhombic system, space group P212121, with a = 5.6793(3) Å, b = 15.2038(7) Å, c = 17.6919(10) Å, Mr = 309.31, V = 1527.64(14) Å3, Z = 4 and R = 0.0547. The compound (4Z)-2-phenyl-4-(3,4,5-trimethoxybenzylidene)-1,3-oxazol-5(4H)-one, C19H17NO5, (6) crystallizes in triclinic geometry with space group P-1, having unit cell parameters a = 7.3814(3) Å, b = 8.1446(3) Å, c = 13.9845(5) Å, α = 86.918(3), β = 83.314(2), γ = 82.462(3), Mr = 339.34, V = 827.16(5) Å3, Z = 2 and R = 0.0433. The DFT calculations of compounds (5) and (6) have been carried out to ascertain the stability of Z-conformer. The in vitro antimicrobial activity of all the compounds (1–6) was evaluated by the disk diffusion method against gram +ve and gram −ve microorganism and fungal strains. The MIC of the synthesized compounds was determined by agar well diffusion method in 96-well microtiter plate. All the synthesized compounds were also screened for their free radical scavenging activity by DPPH method.